variable,level,value
N,,60
"Age, years",,33 [20–42.2]
"Disease duration, years",,2 [0–4]
EDSS,,2 [1–3.5]
Gender,F,47 (78.3%)
Gender,M,13 (21.7%)
Medicine,Betaferon,24 (40%)
Medicine,Rebif,14 (23.3%)
Medicine,Gelenia,9 (15%)
Medicine,Tysabri,8 (13.3%)
Medicine,Avonex,5 (8.3%)
MRI-EDSS < 2 months,No,34 (56.7%)
MRI-EDSS < 2 months,Yes,26 (43.3%)
Comorbidity,No,47 (78.3%)
Comorbidity,Yes,13 (21.7%)
